KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AKTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Akari Therapeutics Plc
(Updated on Apr 26, 2024)

Sell candidate since Mar 14, 2024 Loss -41.91% PDF

The Akari Therapeutics Plc stock price fell by -0.420% on the last day (Friday, 26th Apr 2024) from $1.19 to $1.19. During the last trading day the stock fluctuated 2.56% from a day low at $1.17 to a day high of $1.20. The price has fallen in 6 of the last 10 days and is down by -2.07% for this period. Volume has increased on the last day by 8 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 11 thousand shares were bought and sold for approximately $13.39 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -55.47% during the next 3 months and, with a 90% probability hold a price between $0.359 and $0.592 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AKTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 11, 2024, and so far it has risen 7.73%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akari Therapeutics Plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.19 and $1.58. A break-up above any of these levels will issue buy signals. Akari Therapeutics Plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Akari Therapeutics Plc stock

Akari Therapeutics Plc finds support from accumulated volume at $1.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0300 between high and low, or 2.56%. For the last week, the stock has had daily average volatility of 5.16%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKTX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Akari Therapeutics Plc to open at $1.19, and during the day (based on 14 day Average True Range), to move between $1.07 and $1.30, which gives a possible trading interval of +/-$0.116 (+/-9.81%) up or down from last closing price. If Akari Therapeutics Plc takes out the full calculated possible swing range there will be an estimated 19.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.19 (0.42%) than the support at $1.18 (0.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Akari Therapeutics Plc stock A Buy?

Akari Therapeutics Plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.669 Sell Candidate Unchanged

Predicted Opening Price for Akari Therapeutics Plc of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$1.19 ( 0%) $1.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AKTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.22 2.53 %
R2 1.20 1.56 %
R1 1.20 0.97 %
Current price: 1.19
Support S1 1.17 -0.97 %
S2 1.17 -1.56 %
S3 1.16 -2.53 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.44 21.52 %
R2 1.21 2.11 %
R1 1.19 0.422 %
Current price 1.19
Support S1 1.18 -0.422%
S2 1.16 -2.49%
S3 1.10 -7.17%

FAQ

What is the symbol for Akari Therapeutics Plc Stock and on which exchange is it traded?
The symbol for Akari Therapeutics Plc is AKTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akari Therapeutics Plc Stock?
Akari Therapeutics Plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Akari Therapeutics Plc Stock?
Akari Therapeutics Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akari Therapeutics Plc Stock.

What's the current price of Akari Therapeutics Plc Stock?
As of the end of day on the Apr 26, 2024, the price of an Akari Therapeutics Plc (AKTX) share was $1.19.

What is the 52-week high and low for Akari Therapeutics Plc Stock?
The 52-week high for Akari Therapeutics Plc Stock is $5.50 and the 52-week low is $1.10.

What is the market capitalization of Akari Therapeutics Plc Stock?
As of the Apr 26, 2024, the market capitalization of Akari Therapeutics Plc is 7.874M.

When is the next earnings date for Akari Therapeutics Plc?
The upcoming earnings date for Akari Therapeutics Plc is May 06, 2024.
Click to get the best stock tips daily for free!

About Akari Therapeutics Plc

Akari Therapeutics Plc Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT